Navigation Links
On the road to a new cancer therapy -- starving the tumor
Date:11/1/2007

oncerning the formation of blood vessels, or angiogenesis, to develop new therapies for cancer. Indeed, when the formation of blood vessels that feed tumor cells is blocked, the tumor starves due to the lack of oxygen and nutrients. The existing anti-angiogenesis drugs eliminate the most important angiogenetic growth factor. Unfortunately, this treatment induces side effects, and in addition the cancer compensates by producing other growth factors, so that the drug loses it effect. Therefore, new anti-angiogenesis treatments are needed urgently.

For several years now, the VIB researchers have been investigating a new angiogenetic growth factor: the placental growth factor, or PLGF. Oddly enough, PLGF only stimulates blood vessel formation in cancer and other diseases, but not in a fetus, young children or pregnant women.

New cancer therapy?

VIB researcher Christian Fischer and his colleagues − under the direction of Peter Carmeliet and in close collaboration with the biotech company ThromboGenics directed by Dsir Collen − have been studying the therapeutic possibilities of anti-PLGF, which retards the action of PLGF. Anti-PLGF not only increases the effectiveness of chemotherapy and the current anti-angiogenesis therapy, but it also inhibits the growth and metastasis of tumors that are resistant to existing drugs. In contrast to the current therapies, anti-PLGF does not trigger a rescue operation in which other growth factors are produced as compensation. Another very important consideration is that anti-PLGF induces absolutely no side effects.

The favorable evaluation of anti-PLGF as a potential cancer treatment raises hope for a more effective cancer therapy with fewer side effects − which can be used with children and pregnant women, too. Furthermore, new results indicate that anti-PLGF can also be useful for the treatment of diseases of the eye that lead to blindness. ThromboGenics is focusing on the furt
'/>"/>

Contact: Evy Vierstraete
evy.vierstraete@vib.be
329-244-6611
VIB, Flanders Institute for Biotechnology
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer
2. Cancer siRNA Oligo Set Version 1.0
3. Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform
4. Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE
5. Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System
6. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
7. Genome Wide Profiling of Paired Cancerous and Normal Breast Tissues and Rapid Interpretation of Gene Expression Data
8. NeoClone gets $750K for ovarian cancer detection
9. Quintessence Biosciences advances cancer drug
10. Medical College receives $1.4M cancer grant
11. GE Healthcare partners with UNC on breast cancer imaging research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 Contract Research Organization ... to relocate into a new 41,500 ft2 facility. The ... currently located at 16825 W. 116th St. in Lenexa, KS. ... times the customized laboratory space, will remain in the Kansas ... was founded more than twenty years ago. Remaining in ...
(Date:4/21/2015)... , April 21, 2015 ... and development, custom automation, and contract manufacturing, and  ... accessible flow cytometry and cell sorting technology for ... develop a novel flow cytometry platform. ... NanoCellect Biomedical has developed a microchip-based cell sorting ...
(Date:4/21/2015)... LEXINGTON, Mass. , April 21, 2015 ... company developing transformative pharmaceutical products for subcutaneous ... its pivotal trial of its investigational proprietary ... treatment of edema associated with congestive heart ... development, scPharmaceuticals is developing a proprietary patch ...
(Date:4/21/2015)... 2015 Leading-edge research into ... will be presented at the 2nd International ... and clinicians from academia, industry and government ... Invibio Biomaterial Solutions. The world-leading solutions provider ... manufacturing and R&D for medical-device manufacturers, holds ...
Breaking Biology Technology:XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 2XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 3NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 2NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 3scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 32nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3
... to Build Upon 2007 ... Record-Breaking Results, NEW YORK, Dec. 20 Underscoring ... breast cancer, the Avon,Foundation today announced the 2008 Avon Walk for Breast ... expand into a,ninth market -- Houston -- to build upon the momentum ...
... 20 ISTO Technologies, Inc., a privately,held orthobiologic company, ... Forum in San Francisco, CA from January 7-8, 2008.,Mitchell ... present on,Tuesday, January 8th at 11:00 a.m. Pacific Time, ... Information about the OneMedPlace Finance Forum may,be found at ...
... 20 CuraGen Corporation,(Nasdaq: CRGN ), a ... appointment of Sean Cassidy, as Vice,President and Chief ... today that David M. Wurzer will step down ... other opportunities, but will remain,with the Company through ...
Cached Biology Technology:Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 2Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 3CuraGen Corporation Announces Appointment of Sean Cassidy as CFO 2CuraGen Corporation Announces Appointment of Sean Cassidy as CFO 3CuraGen Corporation Announces Appointment of Sean Cassidy as CFO 4
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/26/2015)... , March 26, 2015 The ... social, recreation and athletic club, today announced it has ... allow freedom of movement for members and staff, while ... a comprehensive process, we selected FST,s IMID Access system ... convenience for our members and staff, in addition to ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... 2014) -- There are more than a trillion cells called ... Each of these neurons contains millions of proteins that perform ... complex networks of the brain still remains as a mystery ... first time, a group of scientists has been able to ...
... wild-caught caterpillars, its food plants and parasitoids, has been going ... Conservacin Guanacaste (ACG), a protected area of approximately 1200 ... 10,000 species of moths and butterflies are estimated to live ... parasitoid wasps, also numbering thousands of species. However, most of ...
... Engineering (NCE) at New Jersey Institute of Technology (NJIT) will host ... in the Campus Center Atrium. Proceeds from the event will ... NCE Dean,s Fund. "NCE has a long tradition ... them hands-on experiences along the way," said Interim Dean Basil C. ...
Cached Biology News:Watching how the brain works 2Almost 200 new species of parasitoid wasps named after local parataxonomists in Costa Rica 2NJIT's Newark College of Engineering announces honorees for annual Salute to Excellence 2NJIT's Newark College of Engineering announces honorees for annual Salute to Excellence 3
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... Formula variant: With the ... by Murashige and Skoog (1962) ... by Gamborg, et al. (1968). ... contain 4.4 grams of powder ...
... Endostatin. Canine Cytokine EIA Kits,(Competitive ... a line of enzyme-linked immunosorbent assay ... for multiple research applications. The line ... quick and dependable assays. The quantitative ...
... Formula variant: With the ... described by Hoagland and ... Equivalency: Formulated to contain ... powder per liter of ...
Biology Products: